Transport Canada's color vision certification pathway presents a multi-stage clinical and regulatory process that can significantly affect a pilot candidate's career trajectory before a single hour of flight training is logged. This case from Alberta illustrates the sequence precisely: an initial Ishihara plate failure at a Civil Aviation Medical Examiner (CAME) office triggers referral for confirmatory testing, and a subsequent Farnsworth D-15 failure establishing a Deutan (green-weak) deficiency places the applicant squarely in Transport Canada's formal adjudication process. At that stage, the agency will typically issue a Category 1 Medical Certificate carrying a "daylight flying only" limitation — effectively restricting the holder to day VFR operations and foreclosing careers in commercial IFR, airline, or charter operations unless the restriction is successfully challenged through appeal.
The question about the Lantern test reflects a genuine shift in Transport Canada's evaluation posture. Lantern-based assessments — including devices like the Optec 900 and Beyne lantern — were historically used by multiple civil aviation authorities to test practical signal-color discrimination rather than physiological color acuity. However, Transport Canada has moved away from the lantern as a standardized pathway, largely because of inter-device variability and reproducibility concerns that make it difficult to apply the test uniformly across medical examiners and regions. The CAME's characterization of this shift is consistent with regulatory practice as it has evolved. The signal light gun test — in which an applicant demonstrates live identification of ATC light signals at an airport tower — remains referenced in some legacy guidance, but its status as a formal appeal mechanism under current Canadian Aviation Regulations (CARs) is not firmly codified, and Transport Canada's formal appeal process generally does not substitute a field light gun demonstration for clinical testing outcomes.
The most significant alternative pathway now referenced in color vision certification discussions — including by the UK CAA and CASA in Australia — is the Colour Assessment and Diagnosis (CAD) test, a computerized assessment developed at City University London that is considerably more sensitive and standardized than the D-15 panel. Whether Transport Canada formally accepts CAD results as part of an appeal submission is a critical regulatory question the applicant should pursue directly with TC's Civil Aviation Medicine branch, as policy on alternative test acceptance can evolve. Candidates in this situation are strongly advised to retain an aviation medical lawyer or a consultant familiar with TC's appeal adjudication, since the evidentiary standards and submission requirements for lifting a color vision restriction are procedurally specific and the window for timely appeal following initial certificate issuance matters.
For working commercial pilots and operators, color vision restriction cases carry direct operational implications. A Cat 1 Medical with a daylight-only limitation is incompatible with IFR ratings, airline transport pilot certification for scheduled operations, or most Part 135 charter work involving night or instrument conditions. Operators conducting pre-hire medicals or reviewing pilot records should understand that the Deutan deficiency class — the most common form of red-green color vision deficiency — exists on a spectrum of severity, and that a D-15 failure does not uniformly predict operational unsuitability; it triggers a regulatory determination process that may or may not result in restriction depending on the severity of the deficiency and the appeal outcome. This distinction matters increasingly as the pilot shortage continues to pressure hiring pipelines and as aviation medical reform advocates in multiple countries push authorities to modernize color vision standards toward functional, operationally relevant assessments rather than legacy plate and panel tests.
The broader trend across civil aviation authorities globally is a gradual movement toward evidence-based, task-relevant color vision standards that distinguish between individuals who cannot perform safety-critical color discrimination tasks and those whose clinical test failures reflect instrument sensitivity rather than operational impairment. Transport Canada, like the FAA, has been slower to adopt this framework than some European and Pacific Rim authorities, but the regulatory pressure is building. For candidates in the Alberta applicant's position, the immediate practical step is to await the formal medical certificate issuance, document the restriction language precisely, and initiate a consultation with a CAME experienced in color vision appeals before the statutory appeal period expires — a timeline that, once missed, can close the unrestricted certification path entirely.